Publications

Detailed Information

Risk factors of acute cholecystitis after endoscopic common bile duct stone removal

DC Field Value Language
dc.contributor.authorLee, Jun Kyu-
dc.contributor.authorRyu, Ji Kon-
dc.contributor.authorPark, Joo Kyung-
dc.contributor.authorYoon, Won Jae-
dc.contributor.authorLee, Sang Hyub-
dc.contributor.authorLee, Kwang Hyuck-
dc.contributor.authorKim, Yong-Tae-
dc.contributor.authorYoon, Yong Bum-
dc.date.accessioned2010-01-27T06:01:14Z-
dc.date.available2010-01-27T06:01:14Z-
dc.date.issued2006-03-08-
dc.identifier.citationWorld J Gastroenterol. 2006 Feb 14;12(6):956-60.en
dc.identifier.issn1007-9327 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16521227-
dc.identifier.urihttps://hdl.handle.net/10371/45508-
dc.description.abstractAIM: To evaluate the risk factors of acute cholecystitis after endoscopic common bile duct (CBD) stone removal. METHODS: A total 100 of patients who underwent endoscopic CBD stone removal with gallbladder (GB) in situ without subsequent cholecystectomy from January 2000 to July 2004 were evaluated retrospectively. The following factors were considered while evaluating risk factors for the development of acute cholecystitis: age, gender, serum bilirubin level, GB wall thickening, cystic duct patency, presence of a GB stone, CBD diameter, residual stone, lithotripsy, juxtapapillary diverticulum, presence of liver cirrhosis or diabetes mellitus, a presenting illness of cholangitis or pancreatitis, and procedure-related complications. RESULTS: During a mean 18-mo follow-up, 28 (28%) patients developed biliary symptoms; 17 (17%) acute cholecystitis and 13 (13%) CBD stone recurrence. Of patients with acute cholecystitis, 15 (88.2%) received laparoscopic cholecystectomy and 2 (11.8%) open cholecystectomy. All recurrent CBD stones were successfully removed endoscopically. The mean time elapse to acute cholecystitis was 10.2 mo (1-37 mo) and that to recurrent CBD stone was 18.4 mo. Of the 17 patients who received cholecystectomy, 2 (11.8%) developed recurrent CBD stones after cholecystectomy. By multivariate analysis, a serum total bilirubin level of <1.3 mg/dL and a CBD diameter of <11 mm at the time of stone removal were found to predict the development of acute cholecystitis. CONCLUSION: After CBD stone removal, there is no need for routine prophylactic cholecystectomy. However, patients without a dilated bile duct (<11 mm) and jaundice (<1.3 mg/dL) at the time of CBD stone removal have a higher risk of acute cholecystitis and are possible candidates for prophylactic cholecystectomy.en
dc.language.isoenen
dc.publisherWJG Pressen
dc.subjectCholangiopancreatography, Endoscopic Retrograde/*adverse effectsen
dc.subjectCholecystectomy/*adverse effects/methodsen
dc.subjectCholecystitis, Acute/*epidemiologyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMedical Recordsen
dc.subjectMiddle Ageden
dc.subjectRecurrenceen
dc.subjectRetrospective Studiesen
dc.subjectRisk Factorsen
dc.titleRisk factors of acute cholecystitis after endoscopic common bile duct stone removalen
dc.typeArticleen
dc.contributor.AlternativeAuthor이준규-
dc.contributor.AlternativeAuthor유지곤-
dc.contributor.AlternativeAuthor박주경-
dc.contributor.AlternativeAuthor윤운재-
dc.contributor.AlternativeAuthor이상협-
dc.contributor.AlternativeAuthor이광혁-
dc.contributor.AlternativeAuthor김용태-
dc.contributor.AlternativeAuthor윤용범-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share